Search

everythinglearnresearchcommunity

for

Search:↓

Dutasteride reduces DHT more effectively than finasteride.

Ritlecitinib improves emotional well-being and activity levels in alopecia areata patients.

Adding a second method to PROTACs could improve cancer treatment.

Ruxolitinib treatment may cause eyelash growth.

Tofacitinib may help treat severe childhood alopecia areata, but risks require careful consideration.

Patients were very satisfied with hair regrowth after taking ritlecitinib for alopecia areata.

JAK inhibitors may help improve symptoms in adults with APECED.

Modified steroidal inhibitors showed promise in treating hormone-dependent cancers.

Pazopanib treatment caused rapid hair color loss, possibly indicating its effectiveness.

Ritlecitinib improves hair regrowth satisfaction in alopecia areata patients.

Alternative treatments are needed when Tofacitinib alone fails for alopecia areata.

Baricitinib may not always prevent relapse in alopecia areata.

The treatment combining docetaxel, cisplatin, and 5-FU is feasible and effective for advanced head and neck cancer.

The new chemotherapy combination for advanced lung cancer showed a 35.7% response rate but caused significant side effects.

Oral ritlecitinib and baricitinib are promising treatments for severe alopecia areata due to their balance of effectiveness and safety.

A chemical called 5-Bromo-2′-deoxyuridine caused rapid hair loss in mice by killing certain skin cells through a specific cell death pathway.

Inhibiting ornithine decarboxylase may help prevent certain skin cancers.

AP-1 and TGFß work together to drive resistance in basal cell carcinoma, suggesting new treatment options.

5α-reductase inhibitors may lower the risk of death from bladder cancer.

Most pediatric cancer patients at Muhimbili National Hospital experienced adverse drug reactions during chemotherapy, highlighting the need for careful monitoring.

Abatacept may help some people with alopecia areata regrow hair.

JAK inhibitors can be safely used for alopecia areata in patients with latent hepatitis B or stable tuberculosis with proper monitoring.

Baricitinib effectively treats severe alopecia for up to 104 weeks.

A Brazilian teenager with severe hair loss had total hair regrowth with no side effects after using tofacitinib.

Combining ficlatuzumab and gefitinib can cause severe scarring hair loss.

New compounds with carborane showed anti-androgen effects similar to flutamide.

Tofacitinib helped some young children with severe hair loss grow their hair back without bad side effects.